Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein

The emergence of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern threatens the efficacy of currently approved vaccines and authorized therapeutic monoclonal antibodies (MAbs). It is hence important to continue searching for SARS-CoV-2 broadly neutralizing MA...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shiqi, Wang, Yifan, Wang, Yanxing, Zhang, Chao, Hong, Qin, Gu, Chenjian, Xu, Rong, Wang, Tingfeng, Yang, Yong, Zang, Jinkai, Zhou, Yu, Li, Zuyang, Liu, Qixing, Zhou, Bingjie, Bai, Lulu, Zhu, Yuanfei, Deng, Qiang, Wang, Haikun, Lavillette, Dimitri, Wong, Gary, Xie, Youhua, Cong, Yao, Huang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794075/
https://www.ncbi.nlm.nih.gov/pubmed/34964428
http://dx.doi.org/10.1080/22221751.2021.2024455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794075/
https://www.ncbi.nlm.nih.gov/pubmed/34964428
http://dx.doi.org/10.1080/22221751.2021.2024455

Ejemplares similares